Overview

Published: September 26, 2022. This webinar offers an introduction to Immune Effector Cellular (IEC) Therapy for the treatment of solid tumors. Basem William, MD, MRCP, FACP, from the OhioHealth Blood and Marrow Transplant and Cellular Therapy Program, and Sarah Nikiforow, MD, PhD, from the Dana-Farber Cancer Institute Cell Manipulation Core Facility in Boston, discussed unique challenges and considerations in IEC manufacturing; listed subtypes of IECs in solid tumors, including TILs, CAR-T cells, and TCRs, and examined the need for quality standards.

  • Register
    • Applicant - $100
    • Auditor - $100
    • Committee Member - $100
    • Consultant - $100
    • FACT Staff - Free!
    • Inspector - Free!
    • Inspector Trainee - Free!
    • Non-member - $100
    • Industry Representative - $200
    • Fellow - $50

    Continue

Already registered?
Log in to access.

Log In

Key:

Complete
Failed
Available
Locked
2022 On-Demand Webinar: IEC Therapy for the Treatment of Solid Tumors (Pt 1)
Published September 26, 2022 You must register to access.
2022 On-Demand Webinar: IEC Therapy for the Treatment of Solid Tumors (Pt 2)
Published September 26, 2022 You must register to access.
2022 On-Demand Webinar: IEC Therapy for the Treatment of Solid Tumors (Pt 3)
Published September 26, 2022 You must register to access.
Evaluation for 2022 On-Demand Webinar: IEC Therapy for the Treatment of Solid Tumors
Published September 26, 2022 You must register to access.
Certificate for 2022 On-Demand Webinar: IEC Therapy for the Treatment of Solid Tumors
You must register to access.